Abstract
Chronic μ-opioid agonist treatment leads to dependence with withdrawal on removal of agonist. At the cellular level withdrawal is accompanied by a supersensitization of adenylyl cyclase, an effect that requires inhibitory Gα proteins. Inhibitory Gα protein action is modulated by regulator of G protein signaling (RGS) proteins that act as GTPase activating proteins and reduce the lifetime of Gα-GTP. In this article, we use C6 glioma cells expressing the rat μ-opioid receptor (C6μ) to examine the hypothesis that Gαo alone can mediate μ-opioid agonist induced adenylyl cyclase supersensitivity and that endogenous RGS proteins serve to limit the extent of this supersensitization. C6μ cells were stably transfected with pertussis toxin (PTX)-insensitive Gαo that was either sensitive or insensitive to endogenous RGS proteins. Cells were treated with PTX to uncouple endogenous Gα proteins followed by exposure to the μ-opioid agonists [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin or morphine. Supersensitization was observed in cells expressing wild-type Gα, but this was lost on PTX treatment. In cells expressing PTX-insensitive Gαo supersensitization was recovered, confirming that Gαo alone can support supersensitization. In cells expressing the RGS-insensitive mutant Gαo, there was a greater degree of supersensitization and the concentration of μ-agonist needed to achieve half-maximal supersensitization was reduced by 10-fold. The amount of supersensitization seen did not directly relate to the degree of acute inhibition of adenylyl cyclase. These results demonstrate a role for Gαo in adenylyl cyclase supersensitization after μ-agonist exposure and show that this action is modulated by endogenous RGS proteins.
Footnotes
-
This study was supported by Grants DA04087 (to J.R.T.) and GM39561 (to R.R.N.). Portions of these data have been published in abstract form in FASEB J. 17:A218, abstract 145.6.
-
DOI: 10.1124/jpet.103.064824.
-
ABBREVIATIONS: PTX, pertussis toxin; GIRK, G protein-gated inwardly rectifying K+ channel; MAPK, mitogen-activated protein kinase; RGS, regulator of G protein signaling; GAP, GTPase-activating protein; HEK, human embryonic kidney; ERK, extracellular signal-regulated kinase; IBMX, 3-isobutyl-1-methylxanthine; DAMGO, [d-Ala2,MePhe4,Gly5-ol]enkephalin; PTXi, pertussis toxin-insensitive.
- Received December 22, 2003.
- Accepted March 9, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|